BioSpace News Archive

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Pol Boudes, M.D., Chief Medical Officer, will provide a corporate overview at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-10, 2021.

F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the company’s management team will participate in the H.C. Wainwright Global Life Science Conference and the Oppenheimer & Co 31st Annual Healthcare Conference .

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Mustang’s management team will participate in three virtual investor conferences in March 2021.

Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present at H.C. Wainwright Global Life Sciences Conference, which is being held virtually from March 9-10, 2021.

LLS clinical trials will use the FDA-cleared BioSticker to evaluate correlation of vital signs and select symptoms to treatment [04-March-2021] DENVER , March 4, 2021 /PRNewswire/ -- BioIntelliSense, Inc. , a continuous health monitoring and clinical intelligence company, today announced the company has entered into a strategic partnership with The Leukemia & L

AIVITA Biomedical, a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, today announced that Hans Keirstead , Ph.D., chairman and chief executive officer, will receive Mission Plasticos’ 2021 Global Humanitarian Award

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™

Castlight Health, Inc. (NYSE: CSLT), a leader in healthcare navigation, today announced the addition of three new clinical advisors: Bruce Sherman, M.D., advisor to the National Alliance of Healthcare Purchaser Coalitions; Justin Mohatt, M.D., vice chair and director, Division of Child Psychiatry at Weill Cornell Medicine; and Mohannad Kusti, M.D., M.P.H., regional medical director at Pivot Onsite Innovations.

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has strengthened its leadership team with the appointments of Drs. Stephen Rubino and Barry J. Simon to the Board of Directors

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, March 11, 2021 to report financial results for the year ended December 31, 2020 and discuss recent business highlights.